Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
2.
Nutrients ; 13(1)2021 Jan 08.
Article in English | MEDLINE | ID: covidwho-1067765

ABSTRACT

Reduced magnesium (Mg) intake is a frequent cause of deficiency with age together with reduced absorption, renal wasting, and polypharmacotherapy. Chronic Mg deficiency may result in increased oxidative stress and low-grade inflammation, which may be linked to several age-related diseases, including higher predisposition to infectious diseases. Mg might play a role in the immune response being a cofactor for immunoglobulin synthesis and other processes strictly associated with the function of T and B cells. Mg is necessary for the biosynthesis, transport, and activation of vitamin D, another key factor in the pathogenesis of infectious diseases. The regulation of cytosolic free Mg in immune cells involves Mg transport systems, such as the melastatin-like transient receptor potential 7 channel, the solute carrier family, and the magnesium transporter 1 (MAGT1). The functional importance of Mg transport in immunity was unknown until the description of the primary immunodeficiency XMEN (X-linked immunodeficiency with Mg defect, Epstein-Barr virus infection, and neoplasia) due to a genetic deficiency of MAGT1 characterized by chronic Epstein-Barr virus infection. This and other research reporting associations of Mg deficit with viral and bacterial infections indicate a possible role of Mg deficit in the recent coronavirus disease 2019 (COVID-19) and its complications. In this review, we will discuss the importance of Mg for the immune system and for infectious diseases, including the recent pandemic of COVID-19.


Subject(s)
Aging/physiology , COVID-19/metabolism , Communicable Diseases/metabolism , Magnesium Deficiency/complications , Magnesium/metabolism , Aged , COVID-19/etiology , COVID-19/immunology , COVID-19/virology , Cation Transport Proteins/metabolism , Communicable Diseases/immunology , Communicable Diseases/microbiology , Communicable Diseases/virology , Epstein-Barr Virus Infections/metabolism , Female , Humans , Magnesium/immunology , Magnesium Deficiency/immunology , Magnesium Deficiency/metabolism , Male , SARS-CoV-2/immunology , X-Linked Combined Immunodeficiency Diseases/metabolism
3.
Magnes Res ; 33(2): 21-27, 2020 May 01.
Article in English | MEDLINE | ID: covidwho-607040

ABSTRACT

More and more studies are accumulating about COVID-19. Some aspects of the pathogenesis of the disease recall events occurring in Mg deficiency, such as a drop of T cells, increased plasma concentration of inflammatory cytokines, and endothelial dysfunction. We hypothesize that a low Mg status, which is rather common, might foment the transition from mild to critical clinical manifestations of the disease. Epidemiological, clinical, and fundamental research is needed to clarify the potential role of Mg deficiency in COVID-19.


Subject(s)
Betacoronavirus/pathogenicity , Coronavirus Infections/blood , Magnesium Deficiency/blood , Magnesium/blood , Pneumonia, Viral/blood , Animals , COVID-19 , Coronavirus Infections/epidemiology , Coronavirus Infections/immunology , Coronavirus Infections/virology , Disease Progression , Host-Pathogen Interactions , Humans , Inflammation Mediators/blood , Magnesium Deficiency/epidemiology , Magnesium Deficiency/immunology , Magnesium Deficiency/virology , Pandemics , Pneumonia, Viral/epidemiology , Pneumonia, Viral/immunology , Pneumonia, Viral/virology , Prognosis , SARS-CoV-2 , T-Lymphocytes/immunology , T-Lymphocytes/metabolism , T-Lymphocytes/virology , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL